{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System Gatifloxacin 0.25-8 \u03bcg/mL",
        "BD PhoenixM Automated Microbiology System for use with the antimicrobial agent Gatifloxacin 0.25-8 ug/mL - Gram-negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K060324",
    "Predicate Device Reference 510(k) Number(s)": [
        "PMA N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 11, 2006",
    "Summary Letter Received Date": "May 16, 2006",
    "Submission Date": "May 11, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Gatifloxacin",
        "Escherichia coli",
        "Klebsiella pneumoniae",
        "Proteus mirabilis",
        "Acinetobacter lwoffii",
        "Citrobacter koseri",
        "Citrobacter freundii",
        "Enterobacter aerogenes",
        "Enterobacter cloacae",
        "Klebsiella oxytoca",
        "Morganella morganii",
        "Proteus vulgaris",
        "Staphylococcus",
        "Enterococcus",
        "Streptococcus"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument",
        "BD Phoenix panels"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Broth based microdilution",
        "Redox indicator detection",
        "Turbidity measurement"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration (MIC) determination",
        "Automated short-term incubation",
        "Broth microdilution"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Instrument",
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System Gatifloxacin panels for automated antimicrobial susceptibility testing of Gram-negative and Gram-positive bacteria",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC of Gram-negative and Gram-positive bacteria isolates from pure culture for Enterobacteriaceae, Non-Enterobacteriaceae, and most Gram-positive genera (Staphylococcus, Enterococcus, Streptococcus) using Gatifloxacin 0.25-8 \u03bcg/mL",
    "fda_folder": "Microbiology"
}